Discover the Down Syndrome


tdsaofva.org keyword stats



Most current MSN search phrases:

Pictures Kids Down Syndrome "fetal symptoms of downs syndrome"
fragilexchromosone xyy syndrome
leptin  

Prenatal Downs Diagnosis: Cusp Of A Breakthrough

Until now, prenatal diagnosis of Downs(13  weeks  or  below).
syndrome (Trisomy 21) for the unborn baby has
required an invasive test. This has taken theThe breakthrough was that they managed to
form of an amniocentesis where fluid is takensuccessfully identify and separate the small
from around the fetus in the womb after 14amount of fetal DNA that cross into the
weeks of gestation. The alternative,maternal circulation. This was analyzed via
available about 3 weeks earlier is CVS wherewhat are known as SNP (single nucleotide
a tiny piece of the afterbirth (placenta) ispolymorphisms) tests to identify where there
extracted.was an extra chromosome on set No. 21
(Trisomy  21).
Screening  Tests
Their tests in this study correctly
The screening tests which are non-invasiveidentified 58 of the 60 chromosomal make up.
have varying degrees of detection rates fromAmong the 58 correctly analyzed, two had
a lowly 30% for maternal age alone to aTrisomy 21 (Downs). The two that were not
clearly impressive 85% for a combination ofcorrectly analyzed included one who had Downs
maternal age, fetal nuchal translucencybut labeled as normal (false negative) and
(scan) and maternal serum biochemistry atthe other one was incorrectly identified to
11-14 weeks. This is called the Integratedhave  Downs  syndrome  (false  positive).
Test.
What  does  this  imply?
Research has also shown that fetuses affected
by Downs syndrome have a missing nasal boneThis is potentially quite a major advance.
on an ultrasound scan performed at 11-14Its strength lies in the fact that it does
weeks. This test alone has been shown toaway with an invasive procedure therefore
identify around 70% of Downs syndrome babies.eliminating in a stroke the spectre of
Crucially however, it did not appear to givemiscarriage that hangs over the currently
any advantage over the longer establishedused procedures. This risk is indeed small
nuchal translucency scan performed at thebut quite real and when it occurs, is
same gestation and therefore the uptake hasdevastating.
been  poor.
However, it is important to stress that this
One of the most frustrating weaknesses of allis only an early stage of this potential
screening tests is the fact that they alsobreakthrough.  Here  are  the  facts:
falsely detect unaffected babies,
occasionally leading to unnecessary invasive The study had quite a small sample
diagnostic tests and always causing(60) and it is therefore crucial that it is
significant stress to prospective parents.replicated  in  larger  studies.
The false positive rate of screening tests is
around  5%. There is still a lot of room for
refinement. In this study, whilst the
Moreover, even the most sensitive screeningearliest sample was taken at 8 weeks
test will still miss some babies that aregestation, the first case of Downs was
affected and for all parents this means aidentified at just over 17 weeks. For this to
little  seed of doubt until the baby arrives.be truly useful, it will have to have the
ability to establish the diagnosis early,
Diagnostic  Testsideally in the first trimester. Also the
interval between blood sample collection and
The definitive diagnostic tests mentionedgetting the results need to be reasonably
(amniocentesis and CVS) suffer from oneshort,  lasting  no  more  than 2 or 3 weeks.
Achilles heel: They are invasive and
therefore carry the potential risk of The current diagnostic tests have
provoking miscarriage. This can happenquite a high 99% accuracy rate. This test
regardless of whether the baby is affected bywill need to match that and ideally surpass
Downs syndrome or not. Because of this, thereit.
has been a lot of research activity to find a
risk-free reliable diagnostic prenatal testScience research thrives on this kind of
for Downs Syndrome. This is why the recentchallenge and there is a lot of excitement in
announcement of a development of such a testthe medical research world about this
reported in the medical journal The Lancetpotential  breakthrough.
(Feb.  3,  2007)  has  caused  such  a  stir.
In fact, this research work by Ravgen Inc. in
Maternal  Blood  Testthe United States is not the only current
development in this area. Researchers in Hong
Dr Ravinder Dhallan of Ravgen Inc. hasKong are also reportedly on the verge of a
reported results of a study to diagnose Downssimilar breakthrough but employing a
syndrome for the unborn baby using Maternaldifferent method which utilises placental DNA
blood and therefore practically eliminatingin  maternal  circulation.
the potential risk of miscarriage associated
with the available invasive tests. What DrThese methods might usher in a new era of
Dhallan and colleagues did in this study wassafe and effective prenatal diagnostic tests.
to collect blood from 60 mothers whose medianIf the hurdles are overcome, the rough
age was 34. Eight of the mothers had theirestimate is that the tests may be available
blood samples taken in the first trimesterfor use in about three years.



1 A B C D E F 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 103 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127